142P Bone mineral density (BMD) after three years of adjuvant zoledronic acid (ZA) in postmenopausal oestrogen receptor positive (ER+) early breast cancer (EBC): An observational single centre study.
Saved in:
| Title: | 142P Bone mineral density (BMD) after three years of adjuvant zoledronic acid (ZA) in postmenopausal oestrogen receptor positive (ER+) early breast cancer (EBC): An observational single centre study. |
|---|---|
| Authors: | Harper-Wynne, C.1, Burcombe, R.2 |
| Source: | Annals of Oncology. 2021 Supplement 2, Vol. 32, pS82-S82. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
